Skip to main content

Reacta Biotech

Manchester, United Kingdom

​Reacta Biotech is develop, manufacture and commercialise oral food challenge materials to pharmaceutical standards.

$3.7M raised
Nov 2025
Venture - Series Unknown

Top Investors

Praetura VenturesDevelopment Bank of WalesPerscitus LLPAcceleris CapitalJon Moulton’s family office

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Reacta Biotech

How much funding has Reacta Biotech raised?
Reacta Biotech has raised $3.7M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.
Who are Reacta Biotech's investors?
Reacta Biotech's investors include Praetura Ventures, Development Bank of Wales, Perscitus LLP, Acceleris Capital, Jon Moulton’s family office.
Where is Reacta Biotech headquartered?
Reacta Biotech is headquartered in Manchester, United Kingdom.
What does Reacta Biotech do?
​Reacta Biotech is develop, manufacture and commercialise oral food challenge materials to pharmaceutical standards.
What stage is Reacta Biotech at?
Reacta Biotech is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Reacta Biotech — Funding & Investors." VCBacked, November 11, 2025, https://www.vcbacked.co/company/reacta-biotech. Accessed June 4, 2026.
APA
VCBacked. (2025). Reacta Biotech — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/reacta-biotech
Wikipedia (cite web)
{{cite web |title=Reacta Biotech — Funding & Investors |url=https://www.vcbacked.co/company/reacta-biotech |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .